文献速递新生儿儿童血液肿瘤与免疫儿童内分泌与遗传代谢

新生儿WAS基因相关疾病早期诊断中的基因筛查

[Genetic screening in early diagnosis of neonatal WAS gene-related disorders].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2019-01-01

结论认为新生儿期基因筛查有助于早期识别和干预WAS基因相关疾病。

要点

  • 新生儿期WAS基因相关疾病缺乏特征性表现,易漏诊。
  • 基因筛查可早期检出WAS基因致病或可疑致病变异。
  • 检出变异中7个为首次报道,扩展了变异谱。

核心结论

  • 新生儿期基因筛查对WAS基因相关疾病的早期诊断和早期干预具有重要价值。

主要发现

  • 检出11例(均为男性)携带WAS基因致病或可疑致病变异的新生儿,其中5例为WAS,6例为XLT。
  • WAS患儿中2例在新生儿早期、3例在5~8周龄出现临床表现。
  • 3例XLT新生儿因其他疾病住院,入院后发现血小板减低,经基因检测确诊。
  • 检测到11个WAS基因致病或可疑致病变异,其中7个为首次报道。
  • 3例患儿接受造血干细胞移植治疗,2例治愈。

关键数值与推荐

  • 首次报道的7个变异包括2个移码变异c.138delG和c.388_390del,4个剪接位点变异c.1453+1G>A、c.734+1G>C、c.135G>A和c.1453+3G>C,1个错义变异c.1118C>T。
  • 已报道的4个致病变异为c.777+1G>A、c.107_108delTT、c.436delC和c.1509_*3delAGTG。

临床怎么用

  • 对新生儿期出现不明原因血小板减少或缺乏特异性表现的患儿,可考虑WAS基因筛查以早期识别WAS基因相关疾病。
  • 基因筛查结果可为早期干预(如造血干细胞移植)提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the clinical value of genetic screening for early identification of WAS gene-related disorders in newborns. Methods: This was a retrospective study. Neonatal Genome Project from Children's Hospital of Fudan University collected 5 800 high-risk newborns in the neonatal intensive care unit to study the patients' genetic causes using high-throughput sequencing from January 2016 to December 2017. Eleven newborns (all were boys) with pathogenic or likely pathogenic variants in WAS gene were enrolled. Data of clinical characteristics,gene variants and genotype-phenotype correlation were collected and summarized. Results: Eleven patients included 5 cases with Wiskott-Aldrich syndrome (WAS) and 6 cases with X-linked thrombocytopenia (XLT).Two patients with WAS developed clinical manifestations in the early neonatal period,and 3 patients in 5-8 weeks after birth. Three neonates with XLT were hospitalized for other diseases in the first place.Their platelet count was found to be reduced after admission to hospital, and diagnosis was made after genetic testing. Eleven pathogenic or likely pathogenic variants in WAS gene were identified. Among them, 7 were first reported in this study, including 2 frame shift variants c.138delG and c.388_390del, 4 splicing variants c.1453+1G>A,c.734+1G>C,c.135G>A and c.1453+3G>C, and 1 missense variant c.1118C>T. The other 4 reported variants were c.777+1G>A,c.107_108delTT, c.436delC and c.1509_*3delAGTG. Conclusions: The clinical features of WAS gene-related disorders in neonatal period lack specificity. Genetic screening in newborns plays an important role in the early diagnosis of diseases and provides providing evidence for the early intervention. 目的: 探讨基因筛查用于早期识别新生儿WAS基因相关疾病的临床应用价值。 方法: 2016年1月至2017年12月复旦大学附属儿科医院新生儿基因组计划纳入新生儿重症监护病房中的5 800例高危新生儿,采用高通量测序方法进行遗传病因的分析,检测到的11例携带WAS基因致病或可疑致病变异的新生儿。回顾性总结11例患儿(均为男性)临床特征,并结合基因变异特征,进行表型基因型分析。 结果: 11例患儿中5例为湿疹-血小板减少-免疫缺陷综合征(WAS),6例为X连锁血小板减少症(XLT)。WAS患儿中2例在新生儿早期、3例在5~8周龄出现临床表现。3例XLT新生儿因其他疾病住院治疗,发现血小板减低。检测到WAS基因致病或可疑致病变异11个,其中7个为首次报道的致病或可疑致病变异,包括2个移码变异c.138delG和c.388_390del,4个剪接位点变异c.1453+1G>A、c.734+1G>C、c.135G>A和c.1453+3G>C,1个错义变异c.1118C>T。另外4个已报道致病变异是c.777+1G>A、c.107_108delTT、c.436delC和c.1509_*3delAGTG。3例患儿接受了造血干细胞移植治疗,2例治愈。 结论: WAS基因相关疾病在新生儿期缺乏特征性表现,新生儿期基因筛查有助于早期识别和干预该类疾病。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu X, Yang L, Wang XC, et al. [Genetic screening in early diagnosis of neonatal WAS gene-related disorders]. Zhonghua Er Ke Za Zhi. 2019. PMID: 31216799. doi:10.3760/cma.j.issn.0578-1310.2019.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。